These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 33290806

  • 1. Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
    Gong Y, Li D, Li L, Yang J, Ding H, Zhang C, Wen G, Wu C, Fang Z, Hou S, Yang Y.
    Food Chem Toxicol; 2021 Jan; 147():111912. PubMed ID: 33290806
    [Abstract] [Full Text] [Related]

  • 2. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Wu C, Chen W, Fang M, Boye A, Tao X, Xu Y, Hou S, Yang Y.
    J Ethnopharmacol; 2019 Mar 01; 231():98-112. PubMed ID: 30412748
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K.
    Hepatology; 2009 Apr 01; 49(4):1203-17. PubMed ID: 19263472
    [Abstract] [Full Text] [Related]

  • 4. Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-mediated pSmad3C/3L transformation.
    Fang Gong Y, Hou S, Xu JC, Chen Y, Zhu LL, Xu YY, Chen YQ, Li MM, Li LL, Yang JJ, Yang Y.
    Phytomedicine; 2023 Aug 01; 117():154903. PubMed ID: 37301185
    [Abstract] [Full Text] [Related]

  • 5. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction.
    Yang J, Gong Y, Xu W, Li L, Shi Z, Wang Q, He Y, Zhang C, Luo C, Fang Z, Yang Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug 01; 394(8):1779-1786. PubMed ID: 34191114
    [Abstract] [Full Text] [Related]

  • 6. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C, Li L, Hou S, Shi Z, Xu W, Wang Q, He Y, Gong Y, Fang Z, Yang Y.
    J Ethnopharmacol; 2021 Oct 28; 279():114350. PubMed ID: 34157326
    [Abstract] [Full Text] [Related]

  • 7. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q, Liu G, Yuan H, Wang J, Guo Y, Chen T, Zhai R, Shao D, Ni W, Tai G.
    Oncotarget; 2015 Feb 28; 6(6):4253-65. PubMed ID: 25714018
    [Abstract] [Full Text] [Related]

  • 8. Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously.
    Xu W, Shi Z, Yu X, Xu Y, Chen Y, He Y, Gong Y, Huang C, Tan C, Yang Y.
    Eur J Pharmacol; 2023 Jan 15; 939():175423. PubMed ID: 36509132
    [Abstract] [Full Text] [Related]

  • 9. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
    Liu R, Tang C, Shen A, Luo H, Wei X, Zheng D, Sun C, Li Z, Zhu D, Li T, Wu Z.
    Oncotarget; 2016 Dec 20; 7(51):85079-85096. PubMed ID: 27835881
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways.
    Wang Q, Xu J, Li M, Chen Y, Xu Y, Li L, Gong Y, Yang Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar 20; 397(3):1687-1700. PubMed ID: 37712971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the cpk mouse, a model of autosomal recessive polycystic kidney disease.
    Hama T, Nakanishi K, Sato M, Mukaiyama H, Togawa H, Shima Y, Miyajima M, Nozu K, Nagao S, Takahashi H, Sako M, Iijima K, Yoshikawa N, Suzuki H.
    Am J Physiol Renal Physiol; 2017 Dec 01; 313(6):F1223-F1231. PubMed ID: 28877884
    [Abstract] [Full Text] [Related]

  • 17. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, Okazaki K, Seki T.
    Hepatology; 2007 Jul 01; 46(1):48-57. PubMed ID: 17596875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
    Murata M, Yoshida K, Yamaguchi T, Matsuzaki K.
    World J Gastroenterol; 2014 Nov 07; 20(41):15018-27. PubMed ID: 25386050
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.